Hers GLP-1 Cost: Every Plan, Real Totals, and What to Watch For

What does Hers weight loss actually cost per month?

The short answer: plan on spending $298 to $348 per month once you add the required membership to the cheapest GLP-1 medication options. That range covers the Wegovy Pill at the low end and the Wegovy Pen injection in the middle. Zepbound runs higher still. The oral non-GLP-1 kits start lower — around $69/month on medication alone — but they work through a fundamentally different mechanism and aren't the same class of drug.

Every Hers weight loss plan has two line items on your card: the Weight Loss Membership and the medication itself. These are billed as separate charges, which catches some members off guard. The membership is not optional — you cannot access medication without it. Understanding that structure upfront is the single most useful thing you can do before signing up.

The Hers Weight Loss Membership fee — what it costs and what it covers

The membership runs $39 for your first month, then auto-renews at $149 per month. It does not include medication, and it does not guarantee a prescription — a provider still reviews your intake and determines eligibility. What the membership does cover is access to the care platform: asynchronous messaging with your provider, check-ins as your dose changes, the Hers app with nutrition and lifestyle tools, and the ability to receive a prescription if you qualify.

Over a full year, the membership alone comes to roughly $1,678 ($39 for month one, then $149 for the remaining eleven months). That figure sits on top of whatever medication costs — it's not an all-in price.

• Month 1 membership: $39
• Ongoing membership: $149/month
• Annual membership cost: ~$1,678
• Shipping: free on all orders
• Consultation/intake: free — no separate fee to apply
• Labs: optional add-on, reported at ~$349/year (twice-yearly testing); not required

Every Hers weight loss plan and its real monthly price

Wegovy Pill (oral semaglutide) — from ~$298/month all-in

The Wegovy Pill is brand-name oral semaglutide from Novo Nordisk, FDA-approved for weight management. Hers lists medication pricing starting at $149/month. Add the $149 ongoing membership and you're at $298/month. This is currently the lowest-cost entry point into a GLP-1 at Hers, and it's a genuine brand-name drug — not a compounded version. Lower doses (1.5 mg and 4 mg) fall at the $149/month medication price; higher doses like 9 mg and 25 mg are listed at $299/month for the medication alone, pushing the all-in total to around $448/month.

Wegovy Pen (injectable semaglutide) — from ~$348/month all-in

The injectable Wegovy Pen is the same active molecule as the pill but delivered subcutaneously. Hers lists this starting at $199/month for the medication. Combined with the $149 membership, the monthly total starts at $348. Injectable semaglutide is what most clinical trials studied, and the pen form allows dose titration across Novo Nordisk's standard escalation schedule. This is the closest equivalent to what brand-name Wegovy has always been.

Zepbound (tirzepatide) KwikPen and Vial — pricing varies by dose

Hers offers both the Zepbound KwikPen and the Zepbound Vial through Eli Lilly's direct pricing program. The medication costs are tied to Lilly's LillyDirect cash-pay rates: roughly $299/month at the 2.5 mg starter dose, rising to $399–$449/month at higher maintenance doses. Stacked with the $149 membership, Zepbound at Hers runs from around $448 at the low end to $600/month at mid-dose. These are still materially less than retail pharmacy pricing for brand Zepbound, which exceeds $1,000/month without insurance — but they are a significant step up from the semaglutide options.

Oral non-GLP-1 medication kits — from ~$218/month all-in

For women who don't qualify for or want a GLP-1, Hers offers personalized oral medication kits starting at $69/month on a 10-month prepaid plan. These are non-injectable and don't involve semaglutide or tirzepatide. Instead, a provider may prescribe a combination from metformin, bupropion, naltrexone, and topiramate — appetite suppressants and insulin-sensitizers that have been used off-label for weight management for years. Combined with the membership fee, the all-in starts near $218/month in month two. The $69 rate requires paying 10 months upfront; month-to-month pricing is higher.

These kits are a different category of treatment from GLP-1 medications. The mechanisms differ, the clinical evidence base is narrower, and average outcomes in published literature are more modest. They're a real option for women who have contraindications to GLP-1s or who are waiting on insurance to clear for a brand-name product — but they shouldn't be compared directly to Wegovy or Zepbound.

Compounded semaglutide — largely no longer available

Hers was previously one of the largest telehealth providers of compounded semaglutide. That changed in late 2025 and early 2026. The FDA issued a warning letter to Hers in September 2025 over marketing claims that implied its compounded product was equivalent to FDA-approved Wegovy. Then, in February 2026, Novo Nordisk filed a patent infringement lawsuit against Hims & Hers. By March 2026, the company announced it was limiting compounded semaglutide to cases where a provider determines it is clinically necessary — and stopped advertising it as a standard offering. If you come to Hers looking for compounded semaglutide at the old $49–$99/month price point, that option is effectively gone from the standard menu.

Hidden fees and billing details that matter

The dual-subscription model is the most common source of billing confusion in Hers reviews. The membership renews automatically at $149/month, and medication renews on its own separate schedule. Cancelling one does not cancel the other. Multiple consumer complaints on Trustpilot and ConsumerAffairs cite charges continuing after attempted cancellation, with a 48-hour window required before the next renewal to stop a charge.

• No insurance accepted — all costs are cash-pay
• Membership and medication cancel separately — you must cancel both
• Cancellation requires action at least 48 hours before renewal to avoid a charge
• HSA/FSA may cover the membership (as a care coordination fee) but requires manual reimbursement — Hers does not bill HSA/FSA directly
• Lab work ($349/year optional) is billed separately if you opt in
• Dose escalations may change your medication price — confirm with your provider before titrating
• No in-network pharmacy — medication ships from Hers-affiliated compounding or specialty pharmacies

Hers weight loss annual cost estimate — what a full year runs

A realistic annual budget depends on which medication you're prescribed. Here's how the math works on each path, assuming you stay at a starting dose for the year and skip the optional lab add-on.

• Oral non-GLP-1 kit: membership ($1,678) + medication (~$828 on 10-month plan) = ~$2,506/year
• Wegovy Pill at $149/month medication: membership ($1,678) + medication ($1,788) = ~$3,466/year
• Wegovy Pen at $199/month medication: membership ($1,678) + medication ($2,388) = ~$4,066/year
• Zepbound at $299/month medication (starter dose): membership ($1,678) + medication ($3,588) = ~$5,266/year
• Optional lab add-on: add $349 to any path above

Real-world costs tend to run higher than the floor estimates, because most people titrate to a higher dose as treatment progresses — and at Hers, higher doses cost more. The $199/month Wegovy Pen figure covers the starting doses; the 2.4 mg maintenance dose is priced separately and higher. Budget conservatively.

How Hers pricing compares to competitors

Hers is not the cheapest GLP-1 telehealth option, and the membership structure makes the true cost higher than the headline medication price suggests. Here's how the all-in monthly cost stacks up against three alternatives women often consider.

• Hers (Wegovy Pill, starter dose): ~$298/month all-in — brand-name semaglutide, dual-billing model
• Mochi Health (compounded semaglutide): ~$178/month all-in ($79 membership + $99 medication, flat-rate across all doses) — month-to-month flexibility, no long-term commitment required
• Henry Meds (compounded semaglutide): ~$197–$297/month all-in depending on dose and plan length — all-inclusive pricing with no separate membership fee
• Fridays (compounded semaglutide): ~$150/month on annual plan, up to $249/month month-to-month — includes coaching and provider visits

The key tradeoff: Hers offers brand-name FDA-approved GLP-1s (Wegovy, Zepbound) at prices well below retail pharmacy, which matters if you want a drug that went through FDA's full approval process. Competitors like Mochi, Henry Meds, and Fridays are offering compounded semaglutide — the same active molecule but not reviewed by the FDA for safety, efficacy, or manufacturing quality before sale. Whether that distinction matters to you depends on your risk tolerance and what your provider recommends.

For women specifically navigating perimenopause or menopause, where polypharmacy (multiple medications, including HRT) is common, having a straightforward brand-name drug with a clean regulatory history can simplify conversations with your primary care provider. That's one genuine advantage Hers holds over the compounded-only platforms.

Is the Hers weight loss price worth it?

For the right person, yes — with a clear-eyed understanding of what you're paying for. Hers has shifted its model to center brand-name GLP-1s at cash-pay prices that are a fraction of what a retail pharmacy charges without insurance. The Wegovy Pill at $298/month all-in is a meaningful reduction from the $1,300–$2,000/month retail price. The platform is app-driven and easy to use, the intake process is fast, and shipping is free.

The limitations are real and worth naming. The dual-subscription billing model is confusing enough that consumer complaints about charges post-cancellation are a recurring theme — the Trustpilot rating sits at 3.4 out of 5, with billing and customer service as the most cited pain points. Care is primarily asynchronous; you're messaging with a provider, not doing video visits unless your state requires it. And the membership fee adds nearly $1,700 a year on top of medication before you see a single result.

Hers makes the most sense if you want access to a brand-name GLP-1 at below-retail cash prices, prefer a polished digital experience, and don't need the hands-on clinical relationship that providers like Mochi Health or a local obesity medicine practice offer. It makes less sense if you're on a tight monthly budget and are open to compounded semaglutide — in that case, Mochi Health or Henry Meds will likely cost you less per month, without a separate membership line item.

Women in perimenopause or menopause should also know that Hers is not an HRT platform. If you're considering GLP-1 therapy alongside hormone therapy, you'll need a separate provider for the HRT side — or look at a telehealth platform that handles both.